Teva Pharmaceutical Industries Limited
TEVA
Pozycja w akcjach
#13242
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Cena akcji
$41.51
Ostatnia synchronizacja: 2026-10-16
Kapitalizacja rynkowa
$483.77M
Zmiana (1 dzień)
-0.85%
Zmiana (1 rok)
107.47%
Kraj
IL
Handel Teva Pharmaceutical Industries Limited (TEVA)
Kategoria
Healthcare
Kapitalizacja rynkowa Teva Pharmaceutical Industries Limited(TEVA)
Kapitalizacja rynkowa: $483.77M
Na dzień October 2026 spółka Teva Pharmaceutical Industries Limited ma kapitalizację rynkową wynoszącą $483.77M. Według naszych danych, czyni to Teva Pharmaceutical Industries Limited 13242nd najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Teva Pharmaceutical Industries Limited od 2010 do 2026
TEVA w porównaniu do 5 najpopularniejszych stocks
